scholarly journals Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock

Critical Care ◽  
2010 ◽  
Vol 14 (2) ◽  
pp. R54 ◽  
Author(s):  
Herbert Spapen ◽  
Duc Nguyen ◽  
Joris Troubleyn ◽  
Luc Huyghens ◽  
Johan Schiettecatte
Keyword(s):  
Septic Shock ◽  
Severe Sepsis ◽  
Drotrecogin Alfa ◽  
Drotrecogin Alfa Activated

Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis

2004 ◽  
Vol 53 (10) ◽  
pp. 528-533 ◽  
Author(s):  
M. Brueckmann ◽  
U. Hoffmann ◽  
E. Dvortsak ◽  
S. Lang ◽  
J. J. Kaden ◽  
...  
Keyword(s):  
Severe Sepsis ◽  
Drotrecogin Alfa ◽  
Mononuclear Cells ◽  
Nf Kappa B ◽  
Drotrecogin Alfa Activated

scholarly journals Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis

Critical Care ◽  
2006 ◽  
Vol 10 (3) ◽  
Author(s):  
Jean-Louis Vincent ◽  
James O'Brien ◽  
Arthur Wheeler ◽  
Xavier Wittebole ◽  
Rekha Garg ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Severe Sepsis ◽  
Drotrecogin Alfa ◽  
Clinical Trial Database ◽  
Drotrecogin Alfa Activated
Sign in / Sign up

Export Citation Format

Share Document